General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Jena Valve(SIGNIFICANT) SPEAKER'S BUREAU: Zoll Pharmaceutical (SIGNIFICANT), Bracco(MODEST) RESEARCH/RESEARCH GRANTS: Novartis(NONE) OTHER FINANCIAL BENEFIT: ResMed Foundation(MODEST), Hitachi Inc(NONE)